| Cutaneous T-cell lymphomas: the Sézary syndrome, mycosis fungoides, and related disorders M LUTZNER, R EDELSON, P SCHEIN, IRA GREEN, C KIRKPATRICK, ... Annals of Internal Medicine 83 (4), 534-552, 1975 | 788 | 1975 |
| Advanced diffuse histiocytic lymphoma, a potentially curable disease: results with combination chemotherapy VT Devita JR, GP Canellos, B Chabner, P Schein, SP Hubbard, ... The Lancet 305 (7901), 248-250, 1975 | 651 | 1975 |
| 5-Fluorouracil, doxorubicin, and mitomycin (FAM) combination chemotherapy for advanced gastric cancer JS Macdonald, PS Schein, PV Woolley, T Smythe, W Ueno, D Hoth, ... Annals of internal medicine 93 (4), 533-536, 1980 | 473 | 1980 |
| Bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP) combination chemotherapy in the treatment of advanced diffuse histiocytic lymphoma PS SCHEIN, VT DeVITA Jr, S HUBBARD, BA CHABNER, GP CANELLOS, ... Annals of Internal Medicine 85 (4), 417-422, 1976 | 454 | 1976 |
| Cancer-associated hemolytic-uremic syndrome: analysis of 85 cases from a national registry JB Lesesne, N Rothschild, B Erickson, S Korec, R Sisk, J Keller, M Arbus, ... J Clin Oncol 7 (6), 781-789, 1989 | 366 | 1989 |
| Preferential cutaneous infiltration by neoplastic thymus-derived lymphocytes: Morphologic and functional studies RL EDELSON, CH KIRKPATRICK, EM SHEVACH, PS SCHEIN, ... Annals of Internal Medicine 80 (6), 685-692, 1974 | 300 | 1974 |
| Central nervous system complications in patients with diffuse histiocytic and undifferentiated lymphoma: leukemia revisited PAJ Bunn, PS Schein, PM Banks, VTJ DeVita | 294 | 1976 |
| The use of nicotinamide to modify the toxicity of streptozotocin diabetes without loss of antitumor activity PS Schein, DA Cooney, ML Vernon Cancer research 27 (12), 2324-2332, 1967 | 293 | 1967 |
| Immunosuppressive and cytotoxic chemotherapy: long-term complications PS Schein, SH Winokur Annals of internal medicine 82 (1), 84-95, 1975 | 286 | 1975 |
| The use of drugs in combination for the treatment of cancer: rationale and results VT DeVita, PS Schein New England Journal of Medicine 288 (19), 998-1006, 1973 | 283 | 1973 |
| Prevention of chronic doxorubicin cardiotoxicity in beagles by liposomal encapsulation EH Herman, A Rahman, VJ Ferrans, JA Vick, PS Schein Cancer Research 43 (11), 5427-5432, 1983 | 243 | 1983 |
| Liposomal protection of adriamycin-induced cardiotoxicity in mice A Rahman, A Kessler, N More, B Sikic, G Rowden, P Woolley, PS Schein Cancer research 40 (5), 1532-1537, 1980 | 238 | 1980 |
| A comparison of combination chemotherapy and combined modality therapy for locally advanced gastric carcinoma PS Schein, Gastrointestinal Tumor Study Group Cancer 49 (9), 1771-1777, 1982 | 227 | 1982 |
| Clinical antitumor activity and toxicity of streptozotocin (NSC‐85998) PS Schein, MJ O'connell, J Blom, S Hubbard, IT Magrath, P Bergevin, ... Cancer 34 (4), 993-1000, 1974 | 225 | 1974 |
| Potential for prolonged disease-free survival following combination chemotherapy of non-Hodgkin’s lymphoma PS Schein, BA Chabner, GP Canellos, RC Young, C Berard, VT DeVita Blood 43 (2), 181-189, 1974 | 215 | 1974 |
| Streptozotocin: depression of mouse liver pyridine nucleotides PS Schein, S Loftus Cancer research 28 (8), 1501-1506, 1968 | 211 | 1968 |
| Islet cell tumors: current concepts and management PS Schein, RA DeLELLIS, CR KAHN, P GORDEN, AR KRAFT Annals of Internal Medicine 79 (2), 239-257, 1973 | 196 | 1973 |
| A randomized trial comparing adjuvant fluorouracil, doxorubicin, and mitomycin with no treatment in operable gastric cancer. International Collaborative Cancer Group. RC Coombes, PS Schein, CE Chilvers, J Wils, G Beretta, JM Bliss, ... Journal of Clinical Oncology 8 (8), 1362-1369, 1990 | 191 | 1990 |
| Pancreatic islet cell tumors produced by the combined action of streptozotocin and nicotinamide N Rakieten, BS Gordon, A Beaty, DA Cooney, RD Davis, PS Schein Proceedings of the Society for Experimental Biology and Medicine 137 (1 …, 1971 | 191 | 1971 |
| Carcinoma-associated hemolytic-uremic syndrome: a complication of mitomycin C chemotherapy. JE Cantrell Jr, TM Phillips, PS Schein Journal of Clinical Oncology 3 (5), 723-734, 1985 | 187 | 1985 |
